ADAP Earnings

ADAP reported its FY2025Q1 earnings on 2025-05-13, showcasing a revenue of 7.00M against an estimate of 7.00M, resulting in a 11.2% surprise. The EPS was -0.03, surpassing the expected -0.17 by 82.35% . The stock experienced a -15.31% price change on the earnings day and a -5.86% change over the next five days, reflecting market reactions to the results.

Following ADAP's FY2025Q1 earnings announcement on 2025-05-13, the stock price moved by -15.31% on the day of the release. Over the subsequent five days, it saw a -5.86% change. Historically, ADAP's stock price tends to shift by an average of +12.22% in the 10 days leading up to earnings and -1.96% in the 10 days following, providing insight into potential market.

For 2025/Q3, analysts estimate ADAP’s annual revenue to reach 11.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between ADAP's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ADAP's stock price typically moves by +12.22% in the 10 days before its earnings and -1.96% in the 10 days after. For the upcoming 2025/Q3 earnings, analysts expect an EPS of 0.00 and revenue of 11.00M.

The earnings call summary indicates strong financial performance with TECELRA's successful launch, efficient operations, and promising sales projections. The Q&A session reveals management's confidence in hitting sales targets and expanding treatment centers. While some details were vague, the overall sentiment remains positive, bolstered by strategic cost reductions and a commitment to shareholder interests. Despite no new partnerships or explicit guidance changes, the positive trajectory in sales and operational metrics suggests a favorable stock price movement over the next two weeks.